Profile
Yi Liu was the founder of Kura Oncology, Inc. (2014, Chief Scientific Officer), Intellikine LLC (2007, Vice President-Drug Discovery), and Kumquat Biosciences, Inc. (2018, Chief Executive Officer & Director).
Former jobs include Principal at CuraGen Corp., Chief Scientific Officer at Zeta Acquisition Corp.
III, Principal at SGX Pharmaceuticals, Inc., Head-Drug Design Group at Novartis Institute for Functional Genomics, Inc., and Chief Scientific Officer at Wellspring Biosciences LLC (2012-2014).
Education includes a doctorate from Princeton University, an undergraduate degree from Tsinghua University, and a graduate degree from Beijing University of Technology.
Yi Liu active positions
| Companies | Position | Start |
|---|---|---|
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Founder | 01/11/2018 |
Former positions of Yi Liu
| Companies | Position | End |
|---|---|---|
Wellspring Biosciences LLC
Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases | Chief Tech/Sci/R&D Officer | 01/09/2014 |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Founder | 01/05/2012 |
Zeta Acquisition Corp. III
Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Chief Tech/Sci/R&D Officer | - |
| KURA ONCOLOGY, INC. | Founder | - |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | - |
Training of Yi Liu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Zeta Acquisition Corp. III
Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Miscellaneous |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
Beijing University of Technology
Beijing University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellspring Biosciences LLC
Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases | Health Technology |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Yi Liu
















